1.Anderson, JM. Mammary cancers and pregnancy. BMJ 1979; 1: 1124–1127.
2.White, TT. Prognosis of breast cancer for pregnant and nursing women: analysis of 1413 cases. Surg Gynecol Obstet 1955; 100: 661–666.
3.Smith, LH, Dalrymple, JL, Leiserowitz, GS, Danielsen, B, Gilbert, WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol 2001; 184: 1504–1513.
4. American Cancer Society. Cancer Facts & Figures 2006. Available at www.cancer.org.
5.Ventura, SJ. First birth to older mothers, 1970–86. Am J Public Health 1989; 79: 1675–1677.
6.Shellock, FG, Kanal, E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999; 10: 477–484.
7.Mazonakis, M, Varveris, H, Damilakis, J, et al. . Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 2003; 55: 386–391.
8.Sharp, C, Shrimpton, JC, Bury, RF. Diagnostic Medical Exposures: Advice on Exposure to Ionizing Radiation During Pregnancy. London, UK: National Radiological Protection Board, 1998. ISBN-0-85951-420-X.
9.Osei, EK, Faulkner, K. Fetal doses from radiological examinations. Br J Radiol 1999; 72: 773–780.
10.Middleton, LP, Amin, M, Gwyn, K, et al. . Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 2003; 98: 1055–1060.
11.Shousha, S. Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med 2000; 124: 1053–1060.
12.Ishida, T, Yokoe, T, Kasmu, F, et al. . Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case control study in Japan. Jpn J Cancer Res 1992; 83: 1143–1149.
13.Ring, A, Smith, IE, Ellis, PA. Breast cancer in pregnancy. Ann Oncol 2005; 16: 1855–1860.
14.Mazze, RI, Kallen, B. Reproduction outcome after anaesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 1989; 161: 1178–1185.
15.Duncan, PG, Pope, WDG, Cohen, MM, Greer, N. Foetal risk of anaesthesia and surgery during pregnancy. Anaesthesiology 1986; 64: 790–794.
16.Berry, DL, Theriault, RL, Holmes, FA, et al. . Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17: 855–861.
17.Kuerer, HM, Gwyn, K, Ames, FC, Theriault, RL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 2002; 131: 108–110.
18.Kaufmann, M, von Minckwitz, G, Smith, R, et al. . International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 2003; 21: 2600–2608.
19.Gentilini, O, Cresmonesi, M, Trifiro, G, et al. . Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004; 15: 1348–1351.
20.Keleher, A, 3rdWendt, R, Delpassand, E, Stachowiak, AM, Kuerer, HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulphur colloid. Breast J 2004; 10: 492–495.
21.Doll, DC, Ringenberg, QS, Yarbro, JW. Antineoplastic agents in pregnancy. Semin Oncol 1989; 16: 337–346.
22.Ebert, U, Loffler, H, Kirch, W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997; 74: 207–220.
23.Woo, JC, Yu, T, Hurd, TC. Breast cancer in pregnancy: a literature review. Arch Surg 2003; 138: 91–98.
24.Kalter, H, Warkany, J. Congenital malformations etiologic factors and their role in prevention. Parts I and II. N Engl J Med 1983; 308: 424–431, 491–497.
25.Giacalone, PL, Laffargue, F, Benos, P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer 1999; 86: 2266–2272.
26.Hahn, KME, Johnson, PH, Gordon, N, et al. . Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006; 107: 1219–1226.
27.Potluri, V, Lewis, D, Burton, GV. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of literature. Clin Breast Cancer 2006; 7: 167–170.
28.Lee, KF, Simon, H, Chen, H, Bates, B, Hung, MC, Hauser, C. Requirement for neuregulin receptor erbB-2 in neural and cardiac development. Nature 1995; 378: 394–398.
29.Bader, AA, Schlembach, D, Tarnussino, KF, Pristauz, G, Petru, E. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007; 8: 79–81.
30.Robinson, AC, Watson, WJ, Leslie, KJ. Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy. Lancet Oncol 2007; 8: 738–743.
31.Oksuzoglu, B, Guler, N. An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol 2002; 104: 79.
32.Isaacs, RJ, Hunter, W, Clark, K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy – case report and literature review. Gynecol Oncol 2001; 80: 405–408.
33.Cullins, SL, Pridjian, G, Sutherland, CM. Goldenhars syndrome associated with tamoxifen given to a mother during gestation. JAMA 1994; 271: 1905–1906.
34.Tewari, K, Bonebrake, RG, Asrat, T, Shanberg, AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet 1997; 350: 183.
35.Gralla, RJ, Osoba, D, Kris, MG, et al. . Recommendations for the use of anti-emetics: evidence based, clinical practice guidelines. J Clin Oncol 1999; 17: 2971–2994.
36.Tincello, DG, Johnstone, MJ. Treatment of hyperemesis gravidarum with the 5HT3 antagonist ondansetron. Postgrad Med J 1996; 72: 688–689.
37.Sullivan, CA, Johnson, CA, Roach, H, Martin, RW, Stewart, DK, Morrison, JCA. pilot study of intravenous ondansetron for hyperemesis gravidarum. Am J Obstet Gynecol 1996; 174: 1565–1568.
38.Rodriguez-Pinilla, E, Martinez-Frias, ML. Corticosteroids during pregnancy and oral clefts: a case control study. Teratology 1998; 58: 2–5.
39.Briggs, GC, Freeman, RK, Yaffee, SM. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. Philadelphia: Lippincott Williams & Wilkins, 1998.
40.Smith, TJ, Khatcheressian, J, Lyman, GH, et al. . 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 2006; 19: 3187–3205.
41.National commission on radiological protection. Pregnancy and medical radiation. Ann IRCP 2000; 30.
42.Antypas, C, Sandiols, P, Kouvaris, J, et al. . Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 995–999.
43.Johannson, O, Loman, N, Borg, A, Ollson, H. Pregnancy associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet 1998; 352: 1359–1360.
44.Bonnier, P, Romain, S, Dilhuydy, JM, et al. . Influence of pregnancy on the outcome of breast cancer: a case–control study. Int J Cancer 1997; 72: 720–727.
45.Zemlickis, D, Lishner, M, Degendorfer, P, et al. . Maternal and foetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992; 166: 781–787.
46.Aziz, S, Pervez, S, Khan, S, et al. . Case control study of novel prognostic markers and disease outcome in pregnancy/lactation associated breast carcinoma. Pathol Res Pract 2003; 199: 15–21.